Seeking Alpha

Galena Biopharma (GALE) +6% premarket as it receives a patent from Japan for a Composition of...

Galena Biopharma (GALE) +6% premarket as it receives a patent from Japan for a Composition of Matter and Method of Treatment patent covering Folate Binding Protein peptide variants for use alone or in combination with FBP cancer vaccine E39. The Japanese patent provides exclusivity in the country until 2022, with additional worldwide patent filings pending.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs